1429P Pathological Regression in Patients with Microsatellite Instability (MSI) Receiving Perioperative Atezolizumab in Combination with FLOT Vs. FLOT Alone for Resectable Esophagogastric Adenocarcinoma: Results from the DANTE Trial of the German Gastric Group at the AIO and SAKK
ANNALS OF ONCOLOGY（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined